{"version":"1.0","provider_name":"hollandbio","provider_url":"https:\/\/www.hollandbio.nl\/en\/","title":"Clovis Oncology\u2019s Rubraca\u00ae wordt vergoed in Nederland - hollandbio","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"kJdOQaPEz3\"><a href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/clovis-oncologys-rubraca-wordt-vergoed-in-nederland\/\">Clovis Oncology\u2019s Rubraca\u00ae wordt vergoed in Nederland<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/clovis-oncologys-rubraca-wordt-vergoed-in-nederland\/embed\/#?secret=kJdOQaPEz3\" width=\"600\" height=\"338\" title=\"&#8220;Clovis Oncology\u2019s Rubraca\u00ae wordt vergoed in Nederland&#8221; &#8212; hollandbio\" data-secret=\"kJdOQaPEz3\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.hollandbio.nl\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Clovis Oncology kondigt aan dat vanaf vandaag Rubraca\u00ae (rucaparib) beschikbaar is en vergoed wordt in Nederland. De commissie ter Beoordeling van Oncologische Middelen (BOM) heeft een positieve aanbeveling gedaan voor rucaparib als monotherapie voor de onderhoudsbehandeling van vrouwen met gerecidiveerd platinagevoelige eierstokkanker.3 Rucaparib wordt aangeboden bij daarvoor in&nbsp;aanmerking komende pati\u00ebnten ongeacht de BRCA-status. Dit betekent [&hellip;]","thumbnail_url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","thumbnail_width":1200,"thumbnail_height":675}